Clinical trials recruiting for Intrahepatic Cholangiocarcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALE.P03 | 1 |
| Hepatic Arterial Infusion Pump chemotherapy with floxuridin | 1 |
| TACE-HAIC, Envafolimab and Lenvatinib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Arizona | 1 |
| Connecticut | 1 |
| Illinois | 1 |
| Kentucky | 1 |
| New Jersey | 1 |
| Texas | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
- D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
- Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
Related conditions
Trials recruiting for Intrahepatic Cholangiocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Intrahepatic Cholangiocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.